Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TAK1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TAK1 is a gene implicated in neurodegeneration research. Key relationships include: activates, regulates, therapeutic target. Associated with Als, Alzheimer, Cancer. Connected to 152 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | TAK1 |
| Aliases | Transforming Growth Factor-beta-Activated Kinase 1 |
| Chromosome | 6q15 |
| Protein Family | MAP3K kinases |
| Protein Type | Kinase |
| Function | TAK1 (Transforming Growth Factor-beta-Activated Kinase 1) is a serine/threonine kinase that activates NF-κB and MAPK pathways in response to cytokines (TNF-α, IL-1), TLR ligands, and stress. |
| Molecular Weight | 67 kDa |
| Pathways | NF-κB, MAPK pathway, NF-κB Signaling, MAPK Signaling, MAPK |
| UniProt ID | [O43318](https://www.uniprot.org/uniprot/O43318) |
| GeneCards | TAK1 |
| Human Protein Atlas | TAK1 |
| Associated Diseases | Encephalitis, Multiple Sclerosis, neuroinflammation |
| Interactions | ALOX12, ALZHEIMER, ALZHEIMER DISEASE, ALZHEIMER'S DISEASE, AMPK, AMYLOID |
| KG Connections | 254 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TAK1["TAK1"] -->|"activates"| Cancer["Cancer"]
TAK1["TAK1"] -->|"activates"| Als["Als"]
TAK1["TAK1"] -->|"activates"| Ms["Ms"]
TAK1["TAK1"] -.->|"inhibits"| Als_1["Als"]
TAK1["TAK1"] -->|"therapeutic target"| Cancer_2["Cancer"]
TAK1["TAK1"] -.->|"inhibits"| Tumor["Tumor"]
P38["P38"] -->|"activates"| TAK1["TAK1"]
MAP1LC3["MAP1LC3"] -->|"activates"| TAK1["TAK1"]
IL1B["IL1B"] -->|"activates"| TAK1["TAK1"]
PRDX1["PRDX1"] -->|"activates"| TAK1["TAK1"]
style TAK1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| mitochondrial_transfer | mediates | mechanism | 0.95 |
| TNF-α signaling | regulates | pathway | 0.88 |
| Tumor | activates | disease | 0.85 |
| Cancer | activates | disease | 0.85 |
| POMC neurons | modulates | unknown | 0.85 |
| Als | activates | disease | 0.85 |
| UBIQUITIN | activates | gene | 0.80 |
| CANCER | activates | gene | 0.80 |
| mitochondrial_dysfunction | inhibits | mechanism | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| AUTOPHAGY | activates | gene | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| Colorectal Cancer | activates | disease | 0.65 |
| Sepsis | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Infection | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Huntington | activates | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Multiple Sclerosis | associated_with | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Type 2 Diabetes | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Encephalitis | associated_with | disease | 0.65 |
| PAK1 | associated_with | gene | 0.60 |
| NEK7 | associated_with | gene | 0.60 |
| JNK | associated_with | gene | 0.60 |
| LIMK1 | associated_with | gene | 0.60 |
| RAC1 | associated_with | gene | 0.60 |
| ASC | associated_with | gene | 0.60 |
| GSDMD | associated_with | gene | 0.60 |
| ubiquitination | activates | process | 0.60 |
| Apoptosis | regulates | pathway | 0.60 |
| Inflammasome | regulates | pathway | 0.60 |
| Immune Response | regulates | pathway | 0.60 |
| Pyroptosis | regulates | pathway | 0.60 |
| Necroptosis | regulates | pathway | 0.60 |
| Nf-Κb | interacts_with | pathway | 0.60 |
| OTUD5 | inhibits | gene | 0.60 |
| AND | activates | gene | 0.60 |
| Podocyte | inhibits | cell_type | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MAP3K7 | activates | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| APEX2 | activates | gene | 0.60 |
| ROS | inhibits | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| APP | activates | gene | 0.60 |
| KRAS | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| IL1B | activates | gene | 0.60 |
| PRDX1 | activates | gene | 0.60 |
| TRAF6 | activates | gene | 0.60 |
| CHUK | activates | gene | 0.60 |
| PRDX6 | activates | gene | 0.60 |
| MAPK14 | activates | gene | 0.60 |
| BECN1 | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| ECSIT | activates | gene | 0.60 |
| TLR4 | activates | gene | 0.60 |
| RELA | activates | gene | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| IKBKB | activates | gene | 0.60 |
| IL6 | activates | gene | 0.60 |
| MAPK8 | inhibits | gene | 0.60 |
| JUN | therapeutic_target | gene | 0.60 |
| MAP3K7 | inhibits | gene | 0.60 |
| ERN1 | inhibits | gene | 0.60 |
| RIPK1 | activates | gene | 0.60 |
| ZBP1 | activates | gene | 0.60 |
| RIPK3 | activates | gene | 0.60 |
| RIPK1 | regulates | gene | 0.60 |
| ZBP1 | regulates | gene | 0.60 |
| RIPK3 | regulates | gene | 0.60 |
| NLRP3 | regulates | gene | 0.60 |
| FADD | regulates | gene | 0.60 |
| STUB1 | interacts_with | gene | 0.60 |
| ERK1 | therapeutic_target | gene | 0.60 |
| JNK1 | therapeutic_target | gene | 0.60 |
| TFEB | activates | gene | 0.60 |
| PP2A | activates | gene | 0.60 |
| KEAP1 | activates | gene | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| APP/PS1 | activates | gene | 0.60 |
| LYSOSOME | activates | gene | 0.60 |
| P38 | activates | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| NF-KB | activates | gene | 0.60 |
| NFKB | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TAK1 Pathway Modulators for Hypothalamic Metabolic Disorders | 0.000 | - | Mitochondrial transfer between astrocyte |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TAK1 in their description or question text
No additional research found